Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trialYanjun Zhang, Fengcai Zhu|The Lancet Infectious Diseases|2020Cited by 1.5k
Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genomeYu Chen, Kwok‐Yung Yuen, Weifeng Liang et al.|The Lancet|2013Cited by 839
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Caicun Zhou, Qiming Wang et al.|Journal of Thoracic Oncology|2021Cited by 311
Dissemination, divergence and establishment of H7N9 influenza viruses in ChinaTommy Tsan‐Yuk Lam, Huachen Zhu, Boping Zhou et al.|Nature|2015Cited by 241